Body dissatisfaction can be minor, too bad my nose is so big, or it can be severe, I hate everything about my body.Once you start to think that you have a flaw, your mind runs with the distraction ...

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...

Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

and market demand. The investment landscape in 2025 offers several promising opportunities in high-growth sectors. While market volatility continues to be a challenge, certain areas stand out for ...

A study led by a researcher from the University of Granada and carried out in collaboration with the University of ...

Enbridge faces uncertainty with potential US tariffs on Canadian energy exports, leading to profit-taking as a prudent ...

So, as promised, here are three examples of how we’ve done this and how you can, too—probably much easier and for far less money than ... where the highest-growth companies succeed because ...

In the 2020s, Netflix has faced new challenges, as nearly every legacy streaming platform launched its own streaming service, and Netflix growth stalled following a surge during the pandemic.

Shares in Veru fell by nearly half following the news, despite positive results in preserving lean muscle mass.

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...